Literature DB >> 25830501

Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites.

David Smith1, Patrik Spanel.   

Abstract

The experimental challenges presented by the analysis of trace volatile organic compounds (VOCs) in exhaled breath with the objective of identifying reliable biomarkers are brought into focus. It is stressed that positive identification and accurate quantification of the VOCs are imperative if they are to be considered as discreet biomarkers. Breath sampling procedures are discussed and it is suggested that for accurate quantification on-line real time sampling and analysis is desirable. Whilst recognizing such real time analysis is not always possible and sample collection is often required, objective recognition of the pitfalls involved in this is essential. It is also emphasized that mouth-exhaled breath is always contaminated to some degree by orally generated compounds and so, when possible, analysis of nose-exhaled breath should be performed. Some difficulties in breath analysis are mitigated by the choice of analytical instrumentation used, but no single instrument can provide solutions to all the analytical challenges. Analysis and interpretation of breath analysis data, however acquired, needs to be treated circumspectly. In particular, the excessive use of statistics to treat imperfect mass spectrometry/mobility spectra should be avoided, since it can result in unjustifiable conclusions. It is should be understood that recognition of combinations of VOCs in breath that, for example, apparently describe particular cancer states, will not be taken seriously until they are replicated in other laboratories and clinics. Finally, the inhibiting notion that single biomarkers of infection and disease will not be identified and utilized clinically should be dispelled by the exemplary and widely used single biomarkers NO and H2 and now, as indicated by recent selected ion flow tube mass spectroscopy (SIFT-MS) results, triatomic hydrogen cyanide and perhaps pentane and acetic acid. Hopefully, these discoveries will provide encouragement to research workers to be more open-minded on this important and desirable issue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25830501     DOI: 10.1088/1752-7155/9/2/022001

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  2 in total

1.  Cellular respiration, metabolomics and the search for illicit drug biomarkers in breath: report from PittCon 2017.

Authors:  Joachim Pleil; Jonathan Beauchamp; Wolfram Miekisch
Journal:  J Breath Res       Date:  2017-08-04       Impact factor: 3.262

2.  Metabolic Signatures of Lung Cancer in Sputum and Exhaled Breath Condensate Detected by 1H Magnetic Resonance Spectroscopy: A Feasibility Study.

Authors:  Naseer Ahmed; Tedros Bezabeh; Omkar B Ijare; Renelle Myers; Reem Alomran; Michel Aliani; Zoann Nugent; Shantanu Banerji; Julian Kim; Gefei Qing; Zoheir Bshouty
Journal:  Magn Reson Insights       Date:  2016-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.